Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond

Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond

Date: Wednesday, 3 November 2021 - Thursday, 4 November 2021
Location: Virtual Event


Conference Chair

Holger Becker

Holger Becker
Chief Scientific Officer, microfluidic ChipShop GmbH

Keynote Speakers

Emmanuel Delamarche

Emmanuel Delamarche
Manager Precision Diagnostics, IBM Research - Z├╝rich

Danilo Tagle

Danilo Tagle
Associate Director For Special Initiatives, Office of the Director, National Center for Advancing Translational Sciences at the NIH (NCATS)

James Boiani

James Boiani
Partner, Epstein Becker & Green, P.C.

Peter Ertl

Peter Ertl
Professor of Lab-on-a-Chip Systems, Vienna University of Technology

Paul Yager

Paul Yager
Professor, Department of Bioengineering, University of Washington

Overview

The SARS-CoV-2 Coronavirus Pandemic is evolving and the various variants which currently are driving the pandemic forward are responsible for morbidity, mortality and economic strains globally.

This virtual 2-day conference takes a deep dive on the current role of Microfluidics Technologies in SARS-CoV-2 testing (circa 2021) and expectations for the future role of Microfluidics in the Management of Pandemics.

The conference brings together companies engaged in this space from the larger diagnostics companies to the emerging companies providing technical solutions in this field -- Providing them a platform to present their technology/offering to the community and engage.

In addition to presentations, there will be virtual posters to highlight technologies and late-breaking developments.

This virtual conference is powered by Zoom and chaired by Dr. Holger Becker, Chief Scientific Officer and Co-Founder of microfluidic ChipShop GmbH and a key opinion leader in the microfluidics and lab-on-a-chip field.

Day 1 of the conference is anchored to the US Eastern Daylight Time (EDT) Zone.

Day 2 of the conference is anchored to the Central European Time (CET) Zone.

Agenda Topics

  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
  • Lateral Flow Assays
  • Microfluidics Impact on SARS-CoV-2 Testing: Current Status and Future
    • Technical Solutions for Rapid COVID-19 Testing
  • Nucleic Acid Diagnostic Tests and Rapid Testing: Evolution of the Space
  • Organoids and Organs-on-Chips to Model SARS-CoV-2 Infection Ex Vivo
  • Rapid Biodetection of Pathogens and Threat Identification: Pandemics and Biosurveillance
  • SARS-CoV-2 Rapid Diagnostics and Global Health
  • Vaccine Development

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Yongsheng Cheng, CEO and Co-founder, PixelBiotech GmbH
Andrea Chow, Senior Vice President of Engineering, Ontera Inc.
Jonathan D Posner, Professor of Mechanical Engineering & Chemical Engineering, University of Washington
Jun Ho Son, CTO, Kryptos Biotechnologies, Inc.


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Agenda is not currently available
Add to Calendar ▼2021-11-03 00:00:002021-11-04 00:00:00Europe/LondonMicrofluidics to Address Pandemics - SARS-CoV-2 and BeyondMicrofluidics to Address Pandemics - SARS-CoV-2 and Beyond in Virtual EventVirtual EventSELECTBIOenquiries@selectbiosciences.com